The KLOW Blend combines GHK-Cu, BPC-157, TB-500, and KPV in a single vial - building on our GLOW Blend with the addition of KPV's anti-inflammatory tripeptide research profile. PhaseOne supplies the KLOW Blend to researchers across Australia as a high-purity lyophilised powder, independently HPLC verified at ≥98% purity per batch.
As a four-peptide blend, KLOW does not have a single CAS number or molecular formula - each component retains its own chemical identity within the vial. PhaseOne manufactures it to research-grade standards with full third-party testing, shipped Australia-wide. (!) Full Certificate of Analysis available for every batch view here.
KLOW combines GHK-Cu, BPC-157, TB-500, and KPV in one vial. (!) Read about each individually: GHK-Cu, BPC-157, TB-500, and KPV.
KLOW includes everything in our GLOW Blend plus KPV, adding an anti-inflammatory research dimension to the existing copper-binding, gut, and recovery-related peptide combination.
The KLOW Blend should be stored refrigerated, unreconstituted, and protected from light, and is commonly reconstituted with bacteriostatic water prior to research use. (!) Read our reconstitution guide.
Every batch of the KLOW Blend sold across Australia is independently HPLC tested, with a Certificate of Analysis verifying all four peptide components.
Researchers across Australia studying combined skin, tissue, and inflammatory signalling pathways often choose multi-peptide blends like KLOW to examine several mechanisms within one preparation.
Disclaimer
All products supplied by PhaseOne are intended strictly for laboratory research purposes only. Products are not intended for human consumption, therapeutic use, cosmetic use, veterinary use, or diagnostic applications.
